Threats To Marketplace From Lawmakers, Administration Wearing Thin On Health Care Investors

"There are a significant number of investors who are completely on the sidelines from the industry,” SVB Leerink biopharma analyst Geoffrey Porges said. “And you can pick your ‘until’: until the proposed rule on Medicare international reference pricing is announced, or until the next Democratic debate, or until the election. There’s a lot of ‘until’s.”

from Kaiser Health News https://ift.tt/2ZakWIb